Insiders the Biggest Winners as CervoMed Inc.'s (NASDAQ:CRVO) Market Cap Rises to US$151m
Insiders the Biggest Winners as CervoMed Inc.'s (NASDAQ:CRVO) Market Cap Rises to US$151m
Key Insights
主要見解
- Insiders appear to have a vested interest in CervoMed's growth, as seen by their sizeable ownership
- 53% of the business is held by the top 6 shareholders
- 21% of CervoMed is held by Institutions
- 內部人士似乎對CervoMed的增長有着既得利益,這可以從他們持有的大量股權中看出。
- 前6名股東持有該業務的53%。
- 21%的CervoMed由機構持有。
If you want to know who really controls CervoMed Inc. (NASDAQ:CRVO), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are individual insiders with 35% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
如果你想知道誰真正控制着CervoMed Inc. (NASDAQ:CRVO) ,那麼你需要看看它的股東名冊組成。持有35%股權的個人內部人士是持有最大股份的群體。換句話說,這個群體面臨着最大的上行潛力(或下行風險)。
Clearly, insiders benefitted the most after the company's market cap rose by US$58m last week.
顯然,內部人士在公司市值上漲5800萬美元后獲益最多。
In the chart below, we zoom in on the different ownership groups of CervoMed.
下面的圖表展示了CervoMed的不同持股群體。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240818/0-5a1d7f8705a32efee13a6a5f4a6f2c34-0-a21aa02c586d7d1c73841ff3461c4b10.png/big)
What Does The Institutional Ownership Tell Us About CervoMed?
機構投資者持股情況告訴我們關於CervoMed的什麼?我們可以看到CervoMed確實有機構投資者,並且他們持有公司股份的一部分。這意味着那些機構的分析師已經研究過該股票,並且他們喜歡它。但就像其他任何人一樣,他們可能會犯錯。如果多個機構同時改變對一隻股票的看法,你可能會看到股價快速下跌。因此,值得看一下CervoMed下面的收益歷史。當然,未來才是真正重要的。
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
機構投資者通常將自己的回報與常見的指數回報進行比較。因此,他們通常會考慮購買包括在相關基準指數中的較大公司。
We can see that CervoMed does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at CervoMed's earnings history below. Of course, the future is what really matters.
納斯達克:CRVO收益和營業收入增長2024年8月18日。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240818/0-5a1d7f8705a32efee13a6a5f4a6f2c34-1-55b74e9b3291f0a778cd52ba20dd37dc.png/big)
It would appear that 7.8% of CervoMed shares are controlled by hedge funds. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. Our data shows that Joshua Boger is the largest shareholder with 13% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 9.9% and 8.9%, of the shares outstanding, respectively. John Alam, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors.
CervoMed的內部所有權我們的信息表明,內部人士在CervoMed Inc.保持着相當大的持股。內部人員在這家15,100萬美元的企業中持股5300萬美元。這可能表明創始人仍然擁有很多股份。你可以 點擊此處查看他們是否一直在買賣。
We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.
我們還觀察到,前6大股東持有超過一半的股份登記簿,有一些較小的股東來平衡較大股東的利益。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
雖然研究一個公司的機構持股數據是有意義的,但研究分析師預期增長也是有意義的,因爲很多分析師都有關注這些股票,因此可以很容易地了解預期增長。
Insider Ownership Of CervoMed
一般公衆,通常是個人投資者,持有CervoMed的27%股權。雖然這一持股規模可觀,但如果該決策與其他大股東不一致,可能不足以改變公司政策。
The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間是不同的。我們的數據反映了個別內部人員,至少捕捉到了董事會成員。公司管理業務,但首席執行官即使是董事會成員也必須向董事會負責。
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
大多數人認爲內部所有權是積極的,因爲它可以表示董事會與其他股東的利益相一致。但是,在某些場合下,這個團體的權力過於集中。
Our information suggests that insiders maintain a significant holding in CervoMed Inc.. Insiders have a US$53m stake in this US$151m business. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.
股權投資公司持有CervoMed的9.9%股權。這表明他們在關鍵政策決策中可能發揮影響力。有些投資者可能會因此受到鼓舞,因爲私募股權有時能夠鼓勵制定能夠幫助市場看到公司價值的戰略。此外,這些持有者也可能在上市後退出投資。
General Public Ownership
一般大衆所有權
The general public, who are usually individual investors, hold a 27% stake in CervoMed. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
我發現看一家公司的股權結構非常有趣。但是,爲了真正獲得洞察,我們需要考慮其他信息。以風險爲例-CervoMed有4個警告信號(其中有2個不應被忽視),我們認爲你應該了解。
Private Equity Ownership
股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。
Private equity firms hold a 9.9% stake in CervoMed. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.
內部所有權CervoMed our information suggests that insiders maintain a significant holding in CervoMed Inc.. Insiders have a US$5300萬 stake in this US$15100萬 business. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - CervoMed has 4 warning signs (and 2 which shouldn't be ignored) we think you should know about.
我發現看一家公司的股權結構非常有趣。但是,爲了真正獲得洞察,我們需要考慮其他信息。以風險爲例-CervoMed有4個警告信號(其中有2個不應被忽視),我們認爲你應該了解。
But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.
但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。